1) norethindrone(NID)/treatment
炔诺酮/治疗
2) norethisterone
炔诺酮
1.
The Analysis of Human Urine Metabolites of the Contraceptive Drug Norethisterone by GC-MS;
人尿中避孕药炔诺酮代谢物的GC-MS分析
2.
Analysis of the Uncertainty of the Content and the Content Uniformity in HPLC Determination of Norethisterone Tablets
HPLC法测定炔诺酮片含量及含量均匀度的不确定度分析
3.
In this study,the synthetic hormones such as 17α-ethinylestriadiol,levonorgestrel and norethisterone in sediment were determined by gas chromatography-mass spectrometry(GC-MS).
应用气相色谱-质谱联用技术,建立了底泥中合成激素炔雌醇、左炔诺孕酮和炔诺酮的分析方法,优化了前处理条件。
3) norgestrel
[英][nɔ:'dʒestrəl] [美][nɔr'dʒɛstrəl]
炔诺酮
1.
Study on Drug Delivery System of Poly(methyl vinylsiloxane) and Levonorgestrel by Small Angle Laser Scattering;
左旋18-甲基炔诺酮-硅橡胶缓释体系小角激光散射法研究
4) Norgestrel
[英][nɔ:'dʒestrəl] [美][nɔr'dʒɛstrəl]
炔诺孕酮
1.
Application of Second Derivative Spectrometry to the Determination of Quinestrol and of Spectrophotometry to the Norgestrel of Drphylline in Compound Preparation;
二阶导数分光光度法和紫外分光光度法测定炔诺孕酮炔雌醚片中炔雌醚和炔诺孕酮的含量
2.
OBJECTIVE:Tostudythepermeabilityofleucine-methylglutamate-glutamicacidcopolymerfilmstonorgestrelandtheefectontheirpermeability.
目的：研究炔诺孕酮（ＮＧ）对白氨酸－谷氨酸－谷氨酸甲酯共聚物膜的渗透性及其影响因素。
6) Norethindrone
[英]['nɔ:eθindrəun] [美][nɔr'ɛθɪn,dron]
炔诺酮
1.
Study on Efficacy and Safety of GnRH-a Combined with Norethindrone in the Treatment of Adenomyosis;
GnRH-a联合炔诺酮治疗子宫腺肌病的疗效与安全性研究
2.
Samples were divided into 4 groups: proliferatory phase; secretory phase; secretory phase with mifepristone administration and proliferatory phase with norethindrone administration.
方法 :取 32例子宫肌瘤术后患者的内膜 ,经病理检测 ,分为四组 :增生期、分泌期、分泌期服用米非司酮 ( Mifepristone)及增生期服用妇康片 (炔诺酮 ) ,每组 8例 ,每例均重复实验。
3.
The release behavior of Brilliant blue, fluorouracil and norethindrone from films was investigated.
考察了考马斯亮蓝、5 -氟尿嘧啶和炔诺酮从该共混膜中的释放情况 ,发现药物的疏水性、共混膜的载药量和厚度以及共混组成能直接影响药物的释放行为 。
补充资料：18-甲基炔诺酮
分子式：C22H28O2
分子量：暂无
CAS号：6533-00-2
性质：暂无
制备方法：暂无
用途：避孕药。
分子量：暂无
CAS号：6533-00-2
性质：暂无
制备方法：暂无
用途：避孕药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条